TOBI
Total Payments
$108,895
Transactions
189
Doctors
106
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $33,240 | 47 | 6 |
| 2018 | $230.35 | 17 | 12 |
| 2017 | $75,424 | 125 | 99 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $73,378 | 1 | 67.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,072 | 6 | 24.9% |
| Travel and Lodging | $3,696 | 13 | 3.4% |
| Food and Beverage | $3,249 | 167 | 3.0% |
| Space rental or facility fees (teaching hospital only) | $1,500 | 2 | 1.4% |
Payments by Type
Research
$73,378
1 transactions
General
$35,517
188 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| OPTIMIZING TREATMENT FOR EARLY PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS THE OPTIMIZE MULTICENTER PLACEBO CONTROLLED RANDOMIZED TRIAL DR HAMBLETT | Novartis Pharmaceuticals Corporation | $73,378 | 0 |
Top Doctors Receiving Payments for TOBI
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $74,878 | 3 |
| , MD | Internal Medicine | Cleveland, OH | $7,318 | 7 |
| , MB BCH | Pediatrics | Ann Arbor, MI | $5,935 | 8 |
| , M.D | Pulmonary Disease | New York, NY | $4,982 | 10 |
| , M.D | Pulmonary Disease | Baltimore, MD | $4,801 | 7 |
| , MD | Internal Medicine | Baltimore, MD | $4,733 | 6 |
| , MD | Pediatrics | Orlando, FL | $3,981 | 8 |
| , MD | Pediatric Pulmonology | Seattle, WA | $109.29 | 9 |
| , MD | Pediatric Critical Care Medicine | Toledo, OH | $108.00 | 8 |
| , M.D | Student in an Organized Health Care Education/Training Program | Ann Arbor, MI | $67.25 | 5 |
| , M.D | Pediatric Pulmonology | Cleveland, OH | $63.37 | 5 |
| , M.D | Pediatric Pulmonology | Long Branch, NJ | $53.41 | 3 |
| , MD | Internal Medicine | Long Branch, NJ | $53.41 | 3 |
| , M.D | Pediatric Pulmonology | Long Branch, NJ | $53.41 | 3 |
| , MD | Pediatric Pulmonology | Grand Rapids, MI | $49.62 | 3 |
| , MD | Pediatric Pulmonology | Grand Rapids, MI | $48.02 | 3 |
| , M.D | Pediatric Pulmonology | Grand Rapids, MI | $46.91 | 3 |
| , MD | Pediatrics | Detroit, MI | $38.22 | 2 |
| , MD | Pediatric Pulmonology | Coral Gables, FL | $29.92 | 2 |
| , MD | Internal Medicine | San Francisco, CA | $26.97 | 2 |
| , M.D | Pediatric Pulmonology | Madera, CA | $25.98 | 2 |
| , M.D | Pediatric Pulmonology | Fairfax, VA | $25.06 | 2 |
| , MD | Pediatric Pulmonology | Omaha, NE | $24.03 | 1 |
| , MD | Pediatric Pulmonology | Omaha, NE | $24.03 | 1 |
| , MD | Pediatric Pulmonology | Omaha, NE | $24.03 | 1 |
Ad
Manufacturing Companies
- Novartis Pharmaceuticals Corporation $75,643
- Mylan Specialty L.P. $33,240
- NOVARTIS PHARMACEUTICALS CORPORATION $11.10
Product Information
- Type Drug
- Total Payments $108,895
- Total Doctors 106
- Transactions 189
About TOBI
TOBI is a drug associated with $108,895 in payments to 106 healthcare providers, recorded across 189 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2017 to 2019. In 2019, $33,240 was paid across 47 transactions to 6 doctors.
The most common payment nature for TOBI is "Unspecified" ($73,378, 67.4% of total).
TOBI is associated with 1 research study, including "OPTIMIZING TREATMENT FOR EARLY PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS THE OPTIMIZE MULTICENTER PLACEBO CONTROLLED RANDOMIZED TRIAL DR HAMBLETT" ($73,378).